ERBB2 and breast carcinoma: Menendez et al, study, which, was conducted to investigate the effect of orlistat on breast cancer, showed that in addition to affecting the expression of the Her/neu gene as one of the most critical oncogenes, this medicine stops the cellulite and increasing apoptosis in cancer cells.